Tuesday, July 1, 2014

Novartis Unit Charged By Japan Over Research Data

  • By

  • Ed Silverman

    •  
    The clinical research scandal in Japan has now formally ensnared Novartis NOVN.VX +1.00%. Prosecutors have brought charges against the drug maker’s local unit, and re-arrested a former employee for allegedly altering data in a study involving the Diovan blood pressure drug in order to make the medicine appear better than rival treatments, The Wall Street Journal writes.
    continue to read here
    -

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)